Freedom from progression (FFP) by adding paclitaxel (T) to doxorubicin (A) followed by CMF as adjuvant or primary systemic therapy: 10-yr results of a randomized phase III European Cooperative Trial in Operable Breast Cancer (ECTO) Meeting Abstract
| Authors: | Zambetti, M.; Baselga, J.; Eiermann, W.; Guillem, V.; Semiglazov, V.; Lluch, A.; Sabadell, D.; Bozhok, A.; Byakhov, M. J.; Ojeda, B.; Mansutti, M.; Mariani, G.; Molitemi, A.; Cortes-Funes, H.; Colozza, M.; Pienkowski, T.; Magazzu, D.; Valagussa, P.; Bonadonna, G.; Gianni, L. |
| Abstract Title: | Freedom from progression (FFP) by adding paclitaxel (T) to doxorubicin (A) followed by CMF as adjuvant or primary systemic therapy: 10-yr results of a randomized phase III European Cooperative Trial in Operable Breast Cancer (ECTO) |
| Meeting Title: | 49th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 31 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2013 May 31-Jun 4 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2013-05-20 |
| Language: | English |
| ACCESSION: | WOS:000335419600042 |
| PROVIDER: | wos |
| DOI: | 10.1200/jco.2013.31.15_suppl.537 |
| Notes: | Meeting Abstract: 537 -- Source: Wos |
